3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
645
Pancreatic Neoplasms
392
Carcinoma, Hepatocellular
308
Stomach Neoplasms
252
Rectal Neoplasms
182
Colonic Neoplasms
182
Esophageal Neoplasms
171
Carcinoma, Non-Small-Cell Lung
169
Breast Neoplasms
150
Neoplasms
135
Neoplasm Metastasis
131
Ovarian Neoplasms
123
Cholangiocarcinoma
112
Lung Neoplasms
108
Liver Neoplasms
107
Gastrointestinal Neoplasms
98
Melanoma
87
Biliary Tract Neoplasms
77
Prostatic Neoplasms
75
Endometrial Neoplasms
74
Esophageal Squamous Cell Carcinoma
67
Carcinoma, Renal Cell
57
Squamous Cell Carcinoma of Head and Neck
54
Sarcoma
54
Uterine Cervical Neoplasms
51
Adenocarcinoma Of Esophagus
47
Head and Neck Neoplasms
46
Urinary Bladder Neoplasms
42
Triple Negative Breast Neoplasms
39
Anus Neoplasms
36
Interventions
durvalumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Cancer Unresectable
×
Gastrointestinal
×
90 days
×
Clear all
NCT06591650
2026-05-14
GCND
Fudan University
Phase 2
Recruiting
33 enrolled